Chair(s): Eric Daniel Tenda, Vincent Fallet
Session type: Postgraduate course
Wouter H. van Geffen
Session content
Optimal route to tissue acquisition according to clinical stage and treatment options in lung cancer
Anneloes L. Noordhof
Slides
Discussion and Q&A
Joanna Chorostowska-wynimko
Slides
Discussion and Q&A
Treatment of common mutations in NSCLC, KRAS and EGFR
Wouter H. Van Geffen
Slides
Discussion and Q&A
Discussion and Q&A
Break
Anneloes L. Noordhof
Slides - Chorostowska-Wynimko
Slides - Noordhof
Session aims
to identify optimal route to tissue acquisition in lung cancer, 2. to discuss referral indications for molecular testing, differentiate and interpret appropriate reports 3. to identify and treat common targetable mutations 4. to discuss and compare neo+/-adjuvant versus both and provide up to date algorithms for real life clinical situations.